Tripp Mickle

And so they start to talk about, well, what could we do?

Like, we're literally doing nothing now.

How do we take a step forward of some sort and begin to get our arms around where this technology is going in the future?

In May, Scott Besson and Susie Wiles began to organize conversations within the administration about how it could regulate the industry.

And they began talking to AI companies about what approaches might be okay with the companies.

Now,

This is an administration that's trying to walk a tightrope here, right?

I mean, they have said that we are very pro-innovation.

We don't want any rules.

And so they don't want to fully abandon that idea, but they want to also take a baby step forward or some step forward so that they do have some guardrails in place.

And what they wind up coming up with is this idea of

an up to 90-day window when they could review artificial intelligence models and assess whether or not those models are capable of finding software vulnerabilities.

In essence, it wouldn't tell tech companies what they can't do, but it would allow the government to absorb information about what their technology can do so that the government is prepared for that and can help

other key groups like banks and utilities also be prepared for those risks and so a draft of the executive order is written the administration schedules a signing ceremony in the oval office on thursday may 21st and they begin to ask and invite chief executives to come to washington to be there for this event and in the run-up to that event a couple of things happened

Good to be here.

One, Kevin Hassett, the head of the National Economic Council, goes on Fox TV.

And describes the process that they're considering as something akin to what the FDA does for drug approvals.

This freaks out Silicon Valley constituents and leads to real worry that the administration's going to slow down the development of artificial intelligence and basically just slam the brakes on it.

In the same way that it's like really hard to get a new drug out the door, they fear that it's going to be really hard to get new artificial intelligence models out the door.

And Thursday morning rolls around and it's time for